CCL22 and hepatocellular carcinoma: Yang et al. demonstrated that, in hepatocellular carcinoma (HCC), miR-34a suppresses CD4+CD25+ Treg cell recruitment into the TME by directly targeting CCL22 (Yang et al., 2012).